SIMILAR PATTERNS OF AMINO ACIDS FOR 4C1F_A_X8ZA300_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ddk | IMP-1 METALLOBETA-LACTAMASE (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 8 | VAL A 25HIS A 77HIS A 79ASP A 81HIS A 139CYH A 158LYS A 161HIS A 197 | None ZN A 500 (-3.4A) ZN A 500 (-3.4A) ZN A 501 ( 2.7A) ZN A 500 (-3.3A) ZN A 501 ( 2.4A) ZN A 501 ( 4.5A) ZN A 501 ( 3.4A) | 0.50A | 4c1fA-1ddkA:40.44c1fB-1ddkA:39.3 | 4c1fA-1ddkA:100.004c1fB-1ddkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ddk | IMP-1 METALLOBETA-LACTAMASE (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 5 | VAL A 25HIS A 79LYS A 161ASN A 167HIS A 197 | None ZN A 500 (-3.4A) ZN A 501 ( 4.5A)ACY A 510 (-4.4A) ZN A 501 ( 3.4A) | 0.86A | 4c1fA-1ddkA:40.44c1fB-1ddkA:39.3 | 4c1fA-1ddkA:100.004c1fB-1ddkA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gkr | NON-ATP DEPENDENTL-SELECTIVEHYDANTOINASE (Paenarthrobacteraurescens) |
PF01979(Amidohydro_1) | 5 | VAL A 154HIS A 239HIS A 183ASN A 333HIS A 62 | None ZN A1452 ( 3.4A) ZN A1452 ( 3.1A)None ZN A1453 ( 3.3A) | 1.22A | 4c1fA-1gkrA:undetectable4c1fB-1gkrA:undetectable | 4c1fA-1gkrA:18.714c1fB-1gkrA:18.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hlk | BETA-LACTAMASE, TYPEII (Bacteroidesfragilis) |
no annotation | 7 | TRP A 49HIS A 99HIS A 101ASP A 103HIS A 162CYH A 181HIS A 223 | 113 A2002 (-3.9A) ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1002 ( 3.3A) ZN A1001 (-3.3A) ZN A1002 ( 2.1A)113 A2002 ( 3.6A) | 0.56A | 4c1fA-1hlkA:15.24c1fB-1hlkA:32.3 | 4c1fA-1hlkA:35.654c1fB-1hlkA:35.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l9y | FEZ-1 B-LACTAMASE (Fluoribactergormanii) |
PF00753(Lactamase_B) | 5 | HIS A 116HIS A 118ASP A 120HIS A 196HIS A 263 | ZN A 1 (-3.4A) ZN A 1 ( 3.2A) ZN A 2 ( 2.6A) ZN A 1 ( 3.3A) ZN A 2 ( 3.3A) | 0.92A | 4c1fA-1l9yA:19.04c1fB-1l9yA:18.7 | 4c1fA-1l9yA:24.194c1fB-1l9yA:24.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1m2x | CLASS BCARBAPENEMASE BLAB-1 (Elizabethkingiameningoseptica) |
PF00753(Lactamase_B) | 6 | HIS A 116HIS A 118ASP A 120HIS A 196CYH A 221HIS A 263 | ZN A 901 (-3.3A) ZN A 901 ( 3.1A) ZN A 902 ( 2.5A) ZN A 901 ( 3.2A) ZN A 902 (-2.3A) ZN A 902 (-3.2A) | 0.30A | 4c1fA-1m2xA:30.34c1fB-1m2xA:30.0 | 4c1fA-1m2xA:34.324c1fB-1m2xA:34.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p9e | METHYL PARATHIONHYDROLASE (Pseudomonas sp.WBC-3) |
PF00753(Lactamase_B) | 5 | HIS A 147HIS A 149ASP A 151HIS A 234HIS A 302 | ZN A 402 (-3.5A) ZN A 402 (-3.1A) ZN A 401 (-2.6A) ZN A 402 (-3.3A) ZN A 401 (-3.4A) | 0.75A | 4c1fA-1p9eA:17.24c1fB-1p9eA:17.1 | 4c1fA-1p9eA:23.104c1fB-1p9eA:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qh5 | PROTEIN(HYDROXYACYLGLUTATHIONE HYDROLASE) (Homo sapiens) |
PF00753(Lactamase_B)PF16123(HAGH_C) | 5 | HIS A 54HIS A 56ASP A 58HIS A 110HIS A 173 | ZN A 261 ( 3.4A) ZN A 261 ( 3.3A) ZN A 262 (-2.7A) ZN A 261 (-3.3A) ZN A 262 (-3.3A) | 0.74A | 4c1fA-1qh5A:16.34c1fB-1qh5A:15.3 | 4c1fA-1qh5A:24.824c1fB-1qh5A:24.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sml | PROTEIN(PENICILLINASE) (Stenotrophomonasmaltophilia) |
PF00753(Lactamase_B) | 5 | HIS A 84HIS A 86ASP A 88HIS A 160HIS A 225 | ZN A 271 (-3.2A) ZN A 271 (-3.2A) ZN A 270 (-2.4A) ZN A 271 (-3.2A) ZN A 270 (-3.2A) | 0.81A | 4c1fA-1smlA:18.24c1fB-1smlA:18.3 | 4c1fA-1smlA:23.304c1fB-1smlA:23.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zkp | HYPOTHETICAL PROTEINBA1088 (Bacillusanthracis) |
PF12706(Lactamase_B_2) | 5 | HIS A 59HIS A 61ASP A 63HIS A 134HIS A 211 | ZN A 245 (-3.3A) ZN A 245 (-3.1A) ZN A 246 (-2.7A) ZN A 245 (-3.3A) ZN A 246 (-3.2A) | 0.74A | 4c1fA-1zkpA:3.04c1fB-1zkpA:4.7 | 4c1fA-1zkpA:20.364c1fB-1zkpA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ztc | HYPOTHETICAL PROTEINTM0894 (Thermotogamaritima) |
PF00753(Lactamase_B) | 5 | HIS A 69HIS A 71ASP A 73HIS A 140HIS A 199 | NI A 302 (-3.3A) NI A 302 (-3.2A) NI A 301 (-3.2A) NI A 302 (-3.4A) NI A 301 (-3.4A) | 0.90A | 4c1fA-1ztcA:15.24c1fB-1ztcA:15.1 | 4c1fA-1ztcA:23.584c1fB-1ztcA:23.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a7m | N-ACYL HOMOSERINELACTONE HYDROLASE (Bacillusthuringiensis) |
PF00753(Lactamase_B) | 5 | HIS A 104HIS A 106ASP A 108HIS A 169HIS A 235 | ZN A 252 (-3.3A) ZN A 252 ( 3.2A) ZN A 251 ( 2.7A) ZN A 252 (-3.3A) ZN A 251 (-3.3A) | 0.64A | 4c1fA-2a7mA:16.74c1fB-2a7mA:16.7 | 4c1fA-2a7mA:24.644c1fB-2a7mA:24.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2az4 | HYPOTHETICAL PROTEINEF2904 (Enterococcusfaecalis) |
PF12706(Lactamase_B_2) | 5 | HIS A 92HIS A 94ASP A 96HIS A 167HIS A 404 | ZN A 601 (-3.4A) ZN A 601 (-3.4A) ZN A 602 (-2.8A) ZN A 601 (-3.4A) ZN A 602 (-3.5A) | 0.94A | 4c1fA-2az4A:12.04c1fB-2az4A:11.8 | 4c1fA-2az4A:20.574c1fB-2az4A:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bq8 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Homo sapiens) |
PF00149(Metallophos) | 5 | VAL X 10TRP X 13HIS X 184ASN X 51GLU X 26 | NoneNoneFE2 X1306 (-3.3A)NoneNone | 1.46A | 4c1fA-2bq8X:undetectable4c1fB-2bq8X:undetectable | 4c1fA-2bq8X:22.934c1fB-2bq8X:22.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cbn | RIBONUCLEASE Z (Escherichiacoli) |
PF12706(Lactamase_B_2) | 5 | HIS A 64HIS A 66ASP A 68HIS A 141HIS A 270 | ZN A 401 (-3.4A) ZN A 401 (-3.2A) ZN A 402 (-2.6A) ZN A 401 (-3.4A) ZN A 402 (-3.3A) | 0.77A | 4c1fA-2cbnA:4.34c1fB-2cbnA:9.3 | 4c1fA-2cbnA:22.404c1fB-2cbnA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e7y | TRNASE Z (Thermotogamaritima) |
PF12706(Lactamase_B_2) | 5 | HIS A 48HIS A 50ASP A 52HIS A 134HIS A 244 | ZN A1302 (-3.5A) ZN A1302 (-3.4A) ZN A1301 (-3.2A) ZN A1302 (-3.7A) ZN A1301 (-3.1A) | 0.85A | 4c1fA-2e7yA:2.84c1fB-2e7yA:8.8 | 4c1fA-2e7yA:20.574c1fB-2e7yA:20.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fhx | SPM-1 (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 6 | HIS B 116HIS B 118ASP B 120HIS B 196LYS B 224HIS B 263 | ZN B 317 (-3.4A) ZN B 317 (-3.2A) ZN B 317 ( 4.0A) ZN B 317 ( 3.2A)AZI B 402 (-2.9A)CSO B 221 (-3.5A) | 0.67A | 4c1fA-2fhxB:30.04c1fB-2fhxB:5.3 | 4c1fA-2fhxB:36.474c1fB-2fhxB:36.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gmn | METALLO-BETA-LACTAMASE (Bradyrhizobiumdiazoefficiens) |
PF00753(Lactamase_B) | 5 | HIS A 101HIS A 103ASP A 105HIS A 177HIS A 242 | ZN A 801 (-3.2A) ZN A 801 (-3.1A) ZN A 802 (-2.5A) ZN A 801 (-3.2A) ZN A 802 (-3.2A) | 0.94A | 4c1fA-2gmnA:18.44c1fB-2gmnA:17.9 | 4c1fA-2gmnA:24.824c1fB-2gmnA:24.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i7t | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR73 KDA SUBUNIT (Homo sapiens) |
PF00753(Lactamase_B)PF07521(RMMBL)PF10996(Beta-Casp) | 6 | VAL A 359HIS A 71HIS A 73ASP A 75HIS A 158HIS A 418 | None ZN A 482 (-3.5A) ZN A 482 ( 3.2A) ZN A 481 ( 2.6A) ZN A 482 ( 3.3A) ZN A 481 ( 3.4A) | 1.09A | 4c1fA-2i7tA:7.54c1fB-2i7tA:9.7 | 4c1fA-2i7tA:19.834c1fB-2i7tA:19.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2nyp | BETA-LACTAMASE II (Bacillus cereus) |
PF00753(Lactamase_B) | 6 | HIS A 86HIS A 88ASP A 90HIS A 149LYS A 171HIS A 210 | ZN A 301 (-3.3A) ZN A 301 (-3.1A) ZN A 302 (-3.3A) ZN A 301 (-3.2A)None ZN A 302 (-4.1A) | 0.65A | 4c1fA-2nypA:30.64c1fB-2nypA:29.7 | 4c1fA-2nypA:35.374c1fB-2nypA:35.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2nyp | BETA-LACTAMASE II (Bacillus cereus) |
PF00753(Lactamase_B) | 6 | HIS A 86HIS A 88HIS A 149LYS A 171ASN A 180HIS A 210 | ZN A 301 (-3.3A) ZN A 301 (-3.1A) ZN A 301 (-3.2A)NoneNone ZN A 302 (-4.1A) | 0.81A | 4c1fA-2nypA:30.64c1fB-2nypA:29.7 | 4c1fA-2nypA:35.374c1fB-2nypA:35.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p18 | GLYOXALASE II (Leishmaniainfantum) |
PF00753(Lactamase_B)PF16123(HAGH_C) | 5 | HIS A 76HIS A 78ASP A 80HIS A 139HIS A 210 | ZN A 302 (-3.4A) ZN A 302 ( 3.2A) ZN A 301 ( 2.7A) ZN A 302 ( 3.2A) ZN A 301 ( 3.3A) | 0.72A | 4c1fA-2p18A:3.14c1fB-2p18A:3.2 | 4c1fA-2p18A:23.994c1fB-2p18A:23.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p4z | METAL-DEPENDENTHYDROLASES OF THEBETA-LACTAMASESUPERFAMILY II (Caldanaerobactersubterraneus) |
PF00753(Lactamase_B) | 5 | HIS A 76HIS A 78ASP A 80HIS A 200HIS A 255 | FE A1001 (-3.5A) FE A1001 (-3.3A) FE A1002 (-2.5A) FE A1001 (-3.3A) FE A1002 (-3.5A) | 0.99A | 4c1fA-2p4zA:10.34c1fB-2p4zA:10.3 | 4c1fA-2p4zA:23.554c1fB-2p4zA:23.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q42 | PUTATIVEHYDROXYACYLGLUTATHIONE HYDROLASE 2 (Arabidopsisthaliana) |
PF00753(Lactamase_B)PF16123(HAGH_C) | 5 | HIS A 54HIS A 56ASP A 58HIS A 112HIS A 169 | ZN A 700 (-3.2A) ZN A 700 (-3.2A) FE A 701 (-2.6A) ZN A 700 (-3.3A) FE A 701 (-3.3A) | 0.73A | 4c1fA-2q42A:16.94c1fB-2q42A:16.6 | 4c1fA-2q42A:22.654c1fB-2q42A:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qed | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) |
PF00753(Lactamase_B)PF16123(HAGH_C) | 5 | HIS A 53HIS A 55ASP A 57HIS A 110HIS A 165 | FE A 253 (-3.3A) FE A 253 (-3.2A) FE A 252 (-2.6A) FE A 253 (-3.2A) FE A 252 (-3.2A) | 0.69A | 4c1fA-2qedA:15.74c1fB-2qedA:15.4 | 4c1fA-2qedA:23.924c1fB-2qedA:23.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vw8 | PA1000 (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 5 | HIS A 69HIS A 71ASP A 73HIS A 159HIS A 221 | FE2 A 402 (-3.4A)FE2 A 402 ( 3.2A)FE2 A 401 ( 2.8A)FE2 A 402 ( 3.3A)FE2 A 401 ( 3.4A) | 0.88A | 4c1fA-2vw8A:17.94c1fB-2vw8A:18.0 | 4c1fA-2vw8A:21.124c1fB-2vw8A:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) |
PF00753(Lactamase_B) | 5 | HIS A 56HIS A 58ASP A 60HIS A 132HIS A 192 | NonePG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.81A | 4c1fA-2xf4A:19.64c1fB-2xf4A:6.3 | 4c1fA-2xf4A:23.364c1fB-2xf4A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | HIS A 242HIS A 244ASP A 246HIS A 329HIS A 604 | ZN A1638 (-3.2A) ZN A1638 (-3.0A) ZN A1639 (-2.7A) ZN A1638 (-3.5A) ZN A1639 (-3.3A) | 0.85A | 4c1fA-2xr1A:9.54c1fB-2xr1A:2.7 | 4c1fA-2xr1A:17.174c1fB-2xr1A:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | VAL A 214HIS A 242HIS A 244HIS A 329HIS A 604 | None ZN A1638 (-3.2A) ZN A1638 (-3.0A) ZN A1638 (-3.5A) ZN A1639 (-3.3A) | 0.87A | 4c1fA-2xr1A:9.54c1fB-2xr1A:2.7 | 4c1fA-2xr1A:17.174c1fB-2xr1A:17.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ynt | GIM-1 PROTEIN (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 6 | HIS B 116HIS B 118ASP B 120HIS B 196CYH B 221HIS B 263 | ZN B1297 (-3.2A) ZN B1297 (-3.1A) ZN B1298 (-2.4A) ZN B1297 (-3.2A) ZN B1298 (-2.2A) ZN B1298 (-3.2A) | 0.39A | 4c1fA-2yntB:35.74c1fB-2yntB:35.4 | 4c1fA-2yntB:44.404c1fB-2yntB:44.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ynt | GIM-1 PROTEIN (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 5 | VAL B 67HIS B 116ASP B 120HIS B 196CYH B 221 | None ZN B1297 (-3.2A) ZN B1298 (-2.4A) ZN B1297 (-3.2A) ZN B1298 (-2.2A) | 1.33A | 4c1fA-2yntB:35.74c1fB-2yntB:35.4 | 4c1fA-2yntB:44.404c1fB-2yntB:44.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zo4 | METALLO-BETA-LACTAMASE FAMILY PROTEIN (Thermusthermophilus) |
PF00753(Lactamase_B) | 5 | HIS A 70HIS A 72ASP A 74ASN A 199HIS A 233 | ZN A 318 (-3.4A) ZN A 318 (-3.3A) ZN A 319 (-2.8A)None ZN A 319 (-3.3A) | 0.62A | 4c1fA-2zo4A:20.24c1fB-2zo4A:19.6 | 4c1fA-2zo4A:20.304c1fB-2zo4A:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zo4 | METALLO-BETA-LACTAMASE FAMILY PROTEIN (Thermusthermophilus) |
PF00753(Lactamase_B) | 5 | HIS A 70HIS A 72ASP A 74HIS A 171HIS A 233 | ZN A 318 (-3.4A) ZN A 318 (-3.3A) ZN A 319 (-2.8A) ZN A 318 (-3.3A) ZN A 319 (-3.3A) | 0.66A | 4c1fA-2zo4A:20.24c1fB-2zo4A:19.6 | 4c1fA-2zo4A:20.304c1fB-2zo4A:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zwr | METALLO-BETA-LACTAMASE SUPERFAMILYPROTEIN (Thermusthermophilus) |
PF00753(Lactamase_B) | 5 | HIS A 54HIS A 56ASP A 58HIS A 125HIS A 184 | ZN A 209 (-3.3A) ZN A 209 (-3.2A) ZN A 208 (-2.7A) ZN A 209 (-3.3A) ZN A 208 (-3.2A) | 0.78A | 4c1fA-2zwrA:5.64c1fB-2zwrA:5.4 | 4c1fA-2zwrA:24.584c1fB-2zwrA:24.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3adr | PUTATIVEUNCHARACTERIZEDPROTEIN ST1585 (Sulfurisphaeratokodaii) |
PF00753(Lactamase_B) | 5 | HIS A 58HIS A 60ASP A 62HIS A 148HIS A 207 | ZN A 262 (-3.4A) ZN A 262 (-3.3A) ZN A 263 (-2.7A) ZN A 262 (-3.3A) ZN A 263 (-3.3A) | 0.80A | 4c1fA-3adrA:7.54c1fB-3adrA:16.8 | 4c1fA-3adrA:25.424c1fB-3adrA:25.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3af5 | PUTATIVEUNCHARACTERIZEDPROTEIN PH1404 (Pyrococcushorikoshii) |
PF07521(RMMBL)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | HIS A 256HIS A 258ASP A 260HIS A 344HIS A 618 | ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A) | 0.90A | 4c1fA-3af5A:9.74c1fB-3af5A:2.7 | 4c1fA-3af5A:16.464c1fB-3af5A:16.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d6n | DIHYDROOROTASE (Aquifexaeolicus) |
PF01979(Amidohydro_1) | 5 | HIS A 180ASP A 153HIS A 232ASN A 278HIS A 63 | FLC A 424 (-4.0A) ZN A 423 ( 2.4A)FLC A 424 (-4.8A)FLC A 424 (-4.8A) ZN A 423 ( 3.4A) | 1.27A | 4c1fA-3d6nA:undetectable4c1fB-3d6nA:undetectable | 4c1fA-3d6nA:21.844c1fB-3d6nA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3esh | PROTEIN SIMILAR TOMETAL-DEPENDENTHYDROLASE (Staphylococcusaureus) |
PF00753(Lactamase_B) | 5 | HIS A 108HIS A 110ASP A 112HIS A 185HIS A 251 | None | 0.99A | 4c1fA-3eshA:15.74c1fB-3eshA:15.8 | 4c1fA-3eshA:21.844c1fB-3eshA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3evk | SUPEROXIDE DISMUTASE[FE] (Pyrobaculumaerophilum) |
PF00081(Sod_Fe_N)PF02777(Sod_Fe_C) | 5 | VAL A 136HIS A 90HIS A 161ASP A 176GLU A 179 | None MN A 301 (-3.5A)None MN A 301 (-2.6A)None | 1.34A | 4c1fA-3evkA:undetectable4c1fB-3evkA:undetectable | 4c1fA-3evkA:22.184c1fB-3evkA:22.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fai | BETA-LACTAMASE (Aeromonashydrophila) |
PF00753(Lactamase_B) | 6 | ASP A 120HIS A 196CYH A 221LYS A 224ASN A 233HIS A 263 | ZN A 1 ( 2.5A) ZN A 2 ( 3.2A) ZN A 1 ( 2.2A)SO4 A 311 ( 4.7A)None ZN A 1 ( 3.2A) | 0.92A | 4c1fA-3faiA:29.64c1fB-3faiA:28.8 | 4c1fA-3faiA:27.244c1fB-3faiA:27.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fai | BETA-LACTAMASE (Aeromonashydrophila) |
PF00753(Lactamase_B) | 6 | HIS A 118ASP A 120HIS A 196CYH A 221LYS A 224HIS A 263 | ZN A 2 ( 3.1A) ZN A 1 ( 2.5A) ZN A 2 ( 3.2A) ZN A 1 ( 2.2A)SO4 A 311 ( 4.7A) ZN A 1 ( 3.2A) | 1.05A | 4c1fA-3faiA:29.64c1fB-3faiA:28.8 | 4c1fA-3faiA:27.244c1fB-3faiA:27.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g1p | PROTEIN PHNP (Escherichiacoli) |
PF12706(Lactamase_B_2) | 5 | HIS A 76HIS A 78ASP A 80ASN A 199HIS A 222 | MN A 400 ( 3.4A) MN A 400 ( 3.3A)MLT A 500 ( 2.8A)None MN A 401 (-3.7A) | 1.13A | 4c1fA-3g1pA:2.94c1fB-3g1pA:7.3 | 4c1fA-3g1pA:19.564c1fB-3g1pA:19.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g1p | PROTEIN PHNP (Escherichiacoli) |
PF12706(Lactamase_B_2) | 5 | HIS A 76HIS A 78ASP A 80HIS A 143HIS A 222 | MN A 400 ( 3.4A) MN A 400 ( 3.3A)MLT A 500 ( 2.8A) MN A 400 ( 3.4A) MN A 401 (-3.7A) | 0.88A | 4c1fA-3g1pA:2.94c1fB-3g1pA:7.3 | 4c1fA-3g1pA:19.564c1fB-3g1pA:19.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h3e | UNCHARACTERIZEDPROTEIN TM1679 (Thermotogamaritima) |
PF00753(Lactamase_B) | 5 | HIS A 57HIS A 59ASP A 61HIS A 170HIS A 224 | ZN A 256 (-3.5A) ZN A 256 (-3.2A) ZN A 256 ( 4.5A) ZN A 256 (-3.6A)None | 1.02A | 4c1fA-3h3eA:10.14c1fB-3h3eA:9.6 | 4c1fA-3h3eA:25.784c1fB-3h3eA:25.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hc1 | UNCHARACTERIZED HDODDOMAIN PROTEIN (Geobactersulfurreducens) |
PF08668(HDOD) | 5 | HIS A 217HIS A 216ASP A 237HIS A 192HIS A 121 | FE A 305 (-3.3A) FE A 305 (-3.4A) FE A 306 (-2.8A) FE A 305 (-3.5A) FE A 306 (-3.4A) | 1.21A | 4c1fA-3hc1A:undetectable4c1fB-3hc1A:undetectable | 4c1fA-3hc1A:22.404c1fB-3hc1A:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ie1 | RIBONUCLEASETTHA0252 (Thermusthermophilus) |
PF00753(Lactamase_B)PF07521(RMMBL)PF10996(Beta-Casp) | 5 | HIS A 59HIS A 61ASP A 63HIS A 141HIS A 400 | ZN A 453 (-3.6A) ZN A 453 (-3.4A) ZN A 452 (-2.5A) ZN A 453 (-3.3A) ZN A 452 (-3.3A) | 0.71A | 4c1fA-3ie1A:10.24c1fB-3ie1A:4.3 | 4c1fA-3ie1A:21.364c1fB-3ie1A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kl7 | PUTATIVEMETAL-DEPENDENTHYDROLASE (Parabacteroidesdistasonis) |
PF13483(Lactamase_B_3) | 5 | HIS A 79HIS A 81ASP A 83HIS A 146HIS A 215 | ZN A 302 (-3.5A) ZN A 302 (-3.4A) ZN A 303 (-2.7A) ZN A 302 (-3.3A) ZN A 303 (-3.3A) | 0.93A | 4c1fA-3kl7A:3.74c1fB-3kl7A:2.5 | 4c1fA-3kl7A:24.224c1fB-3kl7A:24.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3l6n | METALLO-BETA-LACTAMASE (Chryseobacteriumindologenes) |
PF00753(Lactamase_B) | 6 | HIS A 96HIS A 98ASP A 100HIS A 159CYH A 178HIS A 220 | ZN A 301 (-3.3A) ZN A 301 (-3.1A) ZN A 302 (-2.5A) ZN A 301 (-3.2A) ZN A 302 (-2.0A) ZN A 302 (-3.6A) | 0.60A | 4c1fA-3l6nA:29.44c1fB-3l6nA:29.1 | 4c1fA-3l6nA:35.834c1fB-3l6nA:35.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3py6 | BETA-LACTAMASE-LIKE (Brucellaabortus) |
PF12706(Lactamase_B_2) | 5 | HIS A 86HIS A 88ASP A 90HIS A 170HIS A 241 | MN A 301 (-3.4A) MN A 301 ( 3.3A) MN A 300 ( 2.6A) MN A 301 ( 3.4A) MN A 300 ( 3.4A) | 0.73A | 4c1fA-3py6A:9.94c1fB-3py6A:10.5 | 4c1fA-3py6A:22.034c1fB-3py6A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q6v | BETA-LACTAMASE (Serratiafonticola) |
PF00753(Lactamase_B) | 6 | HIS A 118ASP A 120HIS A 196CYH A 221LYS A 224HIS A 263 | GOL A 1 (-3.4A) ZN A 2 ( 2.4A)GOL A 1 (-3.5A) ZN A 2 ( 2.2A)GOL A 1 ( 4.6A) ZN A 2 ( 3.3A) | 0.91A | 4c1fA-3q6vA:29.34c1fB-3q6vA:28.7 | 4c1fA-3q6vA:25.214c1fB-3q6vA:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q6v | BETA-LACTAMASE (Serratiafonticola) |
PF00753(Lactamase_B) | 5 | HIS A 118HIS A 196LYS A 224ASN A 233HIS A 263 | GOL A 1 (-3.4A)GOL A 1 (-3.5A)GOL A 1 ( 4.6A)GOL A 1 (-3.4A) ZN A 2 ( 3.3A) | 1.07A | 4c1fA-3q6vA:29.34c1fB-3q6vA:28.7 | 4c1fA-3q6vA:25.214c1fB-3q6vA:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rpc | POSSIBLEMETAL-DEPENDENTHYDROLASE (Veillonellaparvula) |
PF12706(Lactamase_B_2) | 5 | HIS A 69HIS A 71ASP A 73HIS A 129HIS A 223 | ZN A 301 (-3.4A) ZN A 301 (-3.4A) ZN A 302 (-2.8A) ZN A 301 (-3.3A) ZN A 302 (-3.5A) | 0.92A | 4c1fA-3rpcA:7.34c1fB-3rpcA:7.8 | 4c1fA-3rpcA:21.244c1fB-3rpcA:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3x2z | UPF0173METAL-DEPENDENTHYDROLASE TM_1162 (Thermotogamaritima) |
PF12706(Lactamase_B_2) | 5 | HIS A 48HIS A 50ASP A 52HIS A 108HIS A 190 | NI A 301 (-3.5A) NI A 301 (-3.3A) NI A 302 (-2.7A) NI A 301 (-3.4A) NI A 302 (-3.6A) | 0.80A | 4c1fA-3x2zA:10.04c1fB-3x2zA:9.8 | 4c1fA-3x2zA:23.904c1fB-3x2zA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zq4 | RIBONUCLEASE J 1 (Bacillussubtilis) |
PF00753(Lactamase_B)PF07521(RMMBL) | 5 | HIS A 74HIS A 76ASP A 78HIS A 142HIS A 390 | ZN A1557 (-3.0A) ZN A1557 (-3.2A) ZN A1556 (-2.5A) ZN A1557 (-3.3A) ZN A1556 (-3.4A) | 0.85A | 4c1fA-3zq4A:10.34c1fB-3zq4A:3.5 | 4c1fA-3zq4A:16.344c1fB-3zq4A:16.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zwf | ZINCPHOSPHODIESTERASEELAC PROTEIN 1 (Homo sapiens) |
PF00753(Lactamase_B)PF12706(Lactamase_B_2) | 5 | HIS A 62HIS A 64ASP A 66HIS A 182HIS A 313 | ZN A1364 (-3.5A) ZN A1364 ( 3.2A) ZN A1363 ( 2.6A) ZN A1364 ( 3.5A) ZN A1363 ( 3.4A) | 0.80A | 4c1fA-3zwfA:9.44c1fB-3zwfA:9.1 | 4c1fA-3zwfA:23.084c1fB-3zwfA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ad9 | BETA-LACTAMASE-LIKEPROTEIN 2 (Homo sapiens) |
PF00753(Lactamase_B) | 5 | HIS A 77HIS A 79ASP A 81HIS A 145HIS A 199 | ZN A1001 (-3.4A) ZN A1001 (-3.3A) ZN A1000 (-2.8A) ZN A1001 (-3.3A) ZN A1000 (-3.3A) | 0.81A | 4c1fA-4ad9A:19.94c1fB-4ad9A:19.9 | 4c1fA-4ad9A:24.074c1fB-4ad9A:24.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4d1t | METALLO-B-LACTAMASE (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 6 | HIS A 116HIS A 118ASP A 120HIS A 196CYH A 221HIS A 263 | ZN A1292 (-3.2A) ZN A1292 (-3.1A) ZN A1293 (-2.7A) ZN A1292 (-3.2A) ZN A1293 (-2.3A) ZN A1293 (-3.3A) | 0.31A | 4c1fA-4d1tA:31.84c1fB-4d1tA:31.1 | 4c1fA-4d1tA:33.984c1fB-4d1tA:33.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4d1t | METALLO-B-LACTAMASE (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 6 | HIS A 118ASP A 120HIS A 196CYH A 221ASN A 233HIS A 263 | ZN A1292 (-3.1A) ZN A1293 (-2.7A) ZN A1292 (-3.2A) ZN A1293 (-2.3A)None ZN A1293 (-3.3A) | 0.59A | 4c1fA-4d1tA:31.84c1fB-4d1tA:31.1 | 4c1fA-4d1tA:33.984c1fB-4d1tA:33.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4keq | 4-PYRIDOXOLACTONASE (Mesorhizobiumjaponicum) |
PF00753(Lactamase_B) | 5 | HIS A 96HIS A 98ASP A 100HIS A 185HIS A 252 | ZN A 302 (-3.4A) ZN A 302 ( 3.2A) ZN A 301 (-3.1A) ZN A 302 (-3.3A) ZN A 301 ( 3.3A) | 0.81A | 4c1fA-4keqA:14.84c1fB-4keqA:15.6 | 4c1fA-4keqA:23.884c1fB-4keqA:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4le6 | ORGANOPHOSPHORUSHYDROLASE (Pseudomonaspseudoalcaligenes) |
PF00753(Lactamase_B) | 6 | VAL A 55HIS A 139HIS A 141ASP A 143HIS A 226HIS A 294 | EDO A 407 ( 4.8A) ZN A 405 (-3.3A) ZN A 405 ( 3.1A) ZN A 406 (-2.6A) ZN A 405 (-3.1A) ZN A 406 (-3.2A) | 1.34A | 4c1fA-4le6A:4.14c1fB-4le6A:3.1 | 4c1fA-4le6A:21.744c1fB-4le6A:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ojx | 3',5'-CYCLIC-NUCLEOTIDEPHOSPHODIESTERASE 1 (Saccharomycescerevisiae) |
PF02112(PDEase_II) | 5 | HIS A 128HIS A 130ASP A 132HIS A 213HIS A 326 | ZN A 403 (-3.4A) ZN A 403 ( 3.2A) ZN A 404 ( 2.6A) ZN A 403 ( 3.3A) ZN A 404 ( 3.3A) | 0.76A | 4c1fA-4ojxA:8.84c1fB-4ojxA:8.8 | 4c1fA-4ojxA:21.914c1fB-4ojxA:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p62 | METALLO-BETA-LACTAMASE AIM-1 (Pseudomonasaeruginosa) |
PF00753(Lactamase_B) | 5 | HIS A 104HIS A 106ASP A 108HIS A 182HIS A 250 | ZN A 301 (-3.2A) ZN A 301 (-3.1A) ZN A 302 (-2.4A) ZN A 301 (-3.3A) ZN A 302 (-3.1A) | 0.81A | 4c1fA-4p62A:17.64c1fB-4p62A:17.3 | 4c1fA-4p62A:21.484c1fB-4p62A:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q2c | CRISPR-ASSOCIATEDHELICASE CAS3 (Thermobaculumterrenum) |
PF00271(Helicase_C) | 5 | HIS A 172HIS A 171ASP A 237HIS A 138HIS A 52 | NI A1002 ( 3.3A) NI A1002 (-3.3A) NI A1001 ( 2.7A) NI A1002 (-3.3A) NI A1001 (-3.2A) | 1.25A | 4c1fA-4q2cA:undetectable4c1fB-4q2cA:undetectable | 4c1fA-4q2cA:11.674c1fB-4q2cA:11.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qn9 | N-ACYL-PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D (Homo sapiens) |
PF12706(Lactamase_B_2) | 5 | HIS A 185HIS A 187ASP A 189HIS A 253HIS A 343 | ZN A 501 (-3.6A) ZN A 501 ( 3.4A) ZN A 502 ( 2.5A) ZN A 501 ( 3.5A) ZN A 502 ( 3.6A) | 0.81A | 4c1fA-4qn9A:7.34c1fB-4qn9A:7.6 | 4c1fA-4qn9A:22.944c1fB-4qn9A:22.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u4l | BETA-LACTAMASE NDM-1 (Klebsiellapneumoniae) |
PF00753(Lactamase_B) | 7 | HIS A 120HIS A 122ASP A 124HIS A 189CYH A 208LYS A 211HIS A 250 | ZN A 301 (-3.3A) ZN A 301 ( 3.1A) ZN A 302 ( 2.5A) ZN A 301 ( 3.3A) ZN A 302 (-2.2A)3C7 A 303 ( 4.8A)3C7 A 303 ( 2.8A) | 0.53A | 4c1fA-4u4lA:30.74c1fB-4u4lA:30.3 | 4c1fA-4u4lA:32.794c1fB-4u4lA:32.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u4l | BETA-LACTAMASE NDM-1 (Klebsiellapneumoniae) |
PF00753(Lactamase_B) | 5 | VAL A 73HIS A 120ASP A 124HIS A 189CYH A 208 | 3C7 A 303 ( 4.8A) ZN A 301 (-3.3A) ZN A 302 ( 2.5A) ZN A 301 ( 3.3A) ZN A 302 (-2.2A) | 1.21A | 4c1fA-4u4lA:30.74c1fB-4u4lA:30.3 | 4c1fA-4u4lA:32.794c1fB-4u4lA:32.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ubq | BETA-LACTAMASE (Acinetobacterbaumannii) |
no annotation | 7 | HIS A 78HIS A 80ASP A 82HIS A 140CYH A 159LYS A 162HIS A 198 | ZN A 301 (-3.4A) ZN A 301 ( 3.2A) ZN A 302 (-3.0A) ZN A 301 ( 3.3A) ZN A 302 (-1.8A)ACT A 303 (-2.8A) ZN A 302 ( 3.8A) | 0.42A | 4c1fA-4ubqA:40.14c1fB-4ubqA:38.7 | 4c1fA-4ubqA:88.654c1fB-4ubqA:88.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ubq | BETA-LACTAMASE (Acinetobacterbaumannii) |
no annotation | 7 | HIS A 78HIS A 80ASP A 82HIS A 140LYS A 162ASN A 168HIS A 198 | ZN A 301 (-3.4A) ZN A 301 ( 3.2A) ZN A 302 (-3.0A) ZN A 301 ( 3.3A)ACT A 303 (-2.8A)ACT A 303 (-4.4A) ZN A 302 ( 3.8A) | 0.63A | 4c1fA-4ubqA:40.14c1fB-4ubqA:38.7 | 4c1fA-4ubqA:88.654c1fB-4ubqA:88.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ubq | BETA-LACTAMASE (Acinetobacterbaumannii) |
no annotation | 6 | TRP A 29HIS A 78ASP A 82HIS A 140CYH A 159HIS A 198 | None ZN A 301 (-3.4A) ZN A 302 (-3.0A) ZN A 301 ( 3.3A) ZN A 302 (-1.8A) ZN A 302 ( 3.8A) | 1.40A | 4c1fA-4ubqA:40.14c1fB-4ubqA:38.7 | 4c1fA-4ubqA:88.654c1fB-4ubqA:88.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4v0h | METALLO-BETA-LACTAMASE DOMAIN-CONTAININGPROTEIN 1 1 (Homo sapiens) |
PF00753(Lactamase_B) | 5 | HIS A 117HIS A 119ASP A 121HIS A 172HIS A 234 | FE A1242 (-3.5A) FE A1242 (-3.4A) FE A1243 (-2.9A) FE A1242 (-3.4A) FE A1243 (-3.2A) | 0.72A | 4c1fA-4v0hA:14.34c1fB-4v0hA:6.0 | 4c1fA-4v0hA:21.554c1fB-4v0hA:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xpx | BACTERIOHEMERYTHRIN (Methylococcuscapsulatus) |
PF01814(Hemerythrin) | 5 | VAL A 15HIS A 117HIS A 77HIS A 81HIS A 58 | NoneFE2 A 201 (-3.4A)FE2 A 201 (-3.4A)FE2 A 201 (-3.4A)FE2 A 202 (-3.4A) | 1.45A | 4c1fA-4xpxA:undetectable4c1fB-4xpxA:undetectable | 4c1fA-4xpxA:17.604c1fB-4xpxA:17.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xuk | PUTATIVE HYDROLASE (Acinetobactersp. NBRC 100985) |
PF00753(Lactamase_B) | 5 | HIS A 155HIS A 157ASP A 159HIS A 244HIS A 312 | ZN A 402 (-3.5A) ZN A 402 (-3.4A) ZN A 401 (-2.7A) ZN A 402 (-3.3A) ZN A 401 (-3.4A) | 0.71A | 4c1fA-4xukA:3.74c1fB-4xukA:16.0 | 4c1fA-4xukA:21.894c1fB-4xukA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xwt | DR2417 (Deinococcusradiodurans) |
PF00753(Lactamase_B)PF07521(RMMBL) | 5 | HIS A 84HIS A 86ASP A 88HIS A 153HIS A 403 | ZN A 601 (-3.5A) ZN A 601 (-3.1A) ZN A 602 (-2.7A) ZN A 601 (-3.4A) ZN A 602 (-3.2A) | 0.81A | 4c1fA-4xwtA:3.74c1fB-4xwtA:10.3 | 4c1fA-4xwtA:18.934c1fB-4xwtA:18.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zej | METALLO-BETA-LACTAMASE (Pseudomonasstutzeri) |
no annotation | 7 | VAL A 25HIS A 77HIS A 79ASP A 81HIS A 139CYH A 158HIS A 200 | None ZN A 302 ( 3.3A) ZN A 302 (-3.1A) ZN A 301 ( 2.5A) ZN A 302 (-3.3A) ZN A 301 ( 2.1A) ZN A 301 ( 3.3A) | 0.37A | 4c1fA-4zejA:37.04c1fB-4zejA:36.3 | 4c1fA-4zejA:47.414c1fB-4zejA:47.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zo3 | ACYLHOMOSERINELACTONASE (Chryseobacteriumsp. StRB126) |
PF00753(Lactamase_B) | 5 | HIS A 145HIS A 147ASP A 149HIS A 237HIS A 305 | ZN A 401 (-3.3A) ZN A 401 ( 3.2A) ZN A 402 ( 2.6A) ZN A 401 ( 3.2A) ZN A 402 ( 3.3A) | 0.72A | 4c1fA-4zo3A:3.74c1fB-4zo3A:15.8 | 4c1fA-4zo3A:24.924c1fB-4zo3A:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a0t | RIBONUCLEASE J (Streptomycescoelicolor) |
PF00753(Lactamase_B)PF07521(RMMBL) | 5 | HIS A 84HIS A 86ASP A 88HIS A 151HIS A 399 | ZN A1458 (-3.6A) ZN A1458 (-3.5A) ZN A1457 (-2.7A) ZN A1458 (-3.6A) ZN A1457 (-3.5A) | 0.94A | 4c1fA-5a0tA:10.44c1fB-5a0tA:10.0 | 4c1fA-5a0tA:18.354c1fB-5a0tA:18.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a87 | METALLO-BETA-LACTAMASE VIM-5 (Klebsiellapneumoniae) |
PF00753(Lactamase_B) | 6 | HIS A 114HIS A 116ASP A 118HIS A 179CYH A 198HIS A 240 | ZN A1263 (-3.2A) ZN A1263 (-3.0A) ZN A1265 (-2.8A) ZN A1263 (-3.2A) ZN A1265 (-2.2A) ZN A1265 ( 3.3A) | 0.33A | 4c1fA-5a87A:32.64c1fB-5a87A:31.5 | 4c1fA-5a87A:30.124c1fB-5a87A:30.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b1u | METALLO-BETA-LACTAMASE (Serratiamarcescens) |
PF00753(Lactamase_B) | 5 | HIS A 72HIS A 74ASP A 76HIS A 150HIS A 215 | ZN A 301 (-3.2A) ZN A 301 (-3.1A) ZN A 302 ( 2.5A) ZN A 301 (-3.2A) ZN A 302 ( 3.3A) | 0.86A | 4c1fA-5b1uA:17.74c1fB-5b1uA:17.0 | 4c1fA-5b1uA:22.034c1fB-5b1uA:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b3r | IMP-18 (Pseudomonasaeruginosa) |
no annotation | 7 | HIS A 95HIS A 97ASP A 99HIS A 157CYH A 176LYS A 179HIS A 215 | ZN A2001 ( 3.4A) ZN A2001 ( 3.0A)CIT A2003 ( 2.7A) ZN A2001 ( 3.3A) ZN A2002 ( 2.2A)CIT A2003 (-2.6A) ZN A2002 ( 3.0A) | 0.28A | 4c1fA-5b3rA:39.64c1fB-5b3rA:38.4 | 4c1fA-5b3rA:82.894c1fB-5b3rA:82.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b3r | IMP-18 (Pseudomonasaeruginosa) |
no annotation | 6 | HIS A 95HIS A 97HIS A 157LYS A 179ASN A 185HIS A 215 | ZN A2001 ( 3.4A) ZN A2001 ( 3.0A) ZN A2001 ( 3.3A)CIT A2003 (-2.6A)CIT A2003 (-4.0A) ZN A2002 ( 3.0A) | 0.70A | 4c1fA-5b3rA:39.64c1fB-5b3rA:38.4 | 4c1fA-5b3rA:82.894c1fB-5b3rA:82.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b3r | IMP-18 (Pseudomonasaeruginosa) |
no annotation | 5 | VAL A 49HIS A 95HIS A 97ASP A 99HIS A 157 | None ZN A2001 ( 3.4A) ZN A2001 ( 3.0A)CIT A2003 ( 2.7A) ZN A2001 ( 3.3A) | 1.13A | 4c1fA-5b3rA:39.64c1fB-5b3rA:38.4 | 4c1fA-5b3rA:82.894c1fB-5b3rA:82.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b3r | IMP-18 (Pseudomonasaeruginosa) |
no annotation | 5 | VAL A 49HIS A 95HIS A 97HIS A 157ASN A 185 | None ZN A2001 ( 3.4A) ZN A2001 ( 3.0A) ZN A2001 ( 3.3A)CIT A2003 (-4.0A) | 1.08A | 4c1fA-5b3rA:39.64c1fB-5b3rA:38.4 | 4c1fA-5b3rA:82.894c1fB-5b3rA:82.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b7i | CRISPR-ASSOCIATEDNUCLEASE/HELICASECAS3 SUBTYPEI-F/YPEST (Pseudomonasaeruginosa) |
no annotation | 5 | HIS A 221HIS A 220ASP A 315HIS A 149HIS A 352 | CA A1101 (-3.5A) CA A1101 (-3.7A) CA A1102 (-2.6A) CA A1101 (-3.8A) CA A1102 (-3.6A) | 1.24A | 4c1fA-5b7iA:undetectable4c1fB-5b7iA:undetectable | 4c1fA-5b7iA:11.944c1fB-5b7iA:11.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hif | RECONSTRUCTEDLACTONASE ANCESTOR,ANC1-MPH (syntheticconstruct) |
PF00753(Lactamase_B) | 5 | HIS A 114HIS A 116ASP A 118HIS A 200HIS A 268 | ZN A 402 (-3.4A) ZN A 402 (-3.2A) ZN A 401 ( 2.5A) ZN A 402 (-3.4A) ZN A 401 ( 3.2A) | 0.71A | 4c1fA-5hifA:17.04c1fB-5hifA:16.9 | 4c1fA-5hifA:25.274c1fB-5hifA:25.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i0p | BETA-LACTAMASEDOMAIN PROTEIN (Burkholderiaambifaria) |
PF00753(Lactamase_B) | 6 | HIS A 94HIS A 96ASP A 98HIS A 205ASN A 233HIS A 269 | ZN A 400 (-3.6A) ZN A 400 (-3.1A) ZN A 401 (-3.0A) ZN A 400 (-3.4A)None ZN A 401 (-3.5A) | 0.96A | 4c1fA-5i0pA:19.24c1fB-5i0pA:19.0 | 4c1fA-5i0pA:19.294c1fB-5i0pA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iqk | BETA-LACTAMASE RM3 (unculturedbacterium) |
PF00753(Lactamase_B) | 5 | HIS A 108HIS A 110ASP A 112HIS A 186HIS A 254 | ZN A 401 (-3.2A) ZN A 401 (-3.1A) ZN A 402 (-2.4A) ZN A 401 (-3.2A) ZN A 402 (-3.2A) | 0.74A | 4c1fA-5iqkA:17.74c1fB-5iqkA:17.3 | 4c1fA-5iqkA:22.704c1fB-5iqkA:22.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5mmd | METALLO-BETA-LACTAMASE 1 (Acinetobacterbaumannii) |
PF00753(Lactamase_B) | 8 | VAL E 61TRP E 64HIS E 116HIS E 118ASP E 120HIS E 196CYH E 221HIS E 263 | NoneNone ZN E 403 (-3.3A) ZN E 403 (-3.1A) ZN E 401 (-2.5A) ZN E 403 (-3.1A) ZN E 401 (-2.3A) ZN E 401 (-3.3A) | 0.45A | 4c1fA-5mmdE:38.14c1fB-5mmdE:37.1 | 4c1fA-5mmdE:49.574c1fB-5mmdE:49.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mtz | RIBONUCLEASE Z (Saccharomycescerevisiae) |
PF13691(Lactamase_B_4) | 5 | HIS A 540HIS A 542ASP A 544HIS A 670HIS A 759 | ZN A 901 (-3.4A) ZN A 901 ( 3.1A) ZN A 902 ( 2.6A) ZN A 901 ( 3.5A) ZN A 902 ( 3.2A) | 0.83A | 4c1fA-5mtzA:4.94c1fB-5mtzA:6.6 | 4c1fA-5mtzA:13.704c1fB-5mtzA:13.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | VAL A 12TRP A 15HIS A 186ASN A 53GLU A 28 | NoneNone FE A 403 ( 3.4A)NoneNone | 1.44A | 4c1fA-5uq6A:undetectable4c1fB-5uq6A:2.1 | 4c1fA-5uq6A:22.054c1fB-5uq6A:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ao1 | BETA-LACTAMASEDOMAIN PROTEIN (Paraburkholderiaphymatum) |
PF00753(Lactamase_B) | 5 | HIS A 94HIS A 96ASP A 98ASN A 233HIS A 269 | CA A 404 (-3.4A) CA A 404 (-3.2A) CA A 403 (-3.0A)None CA A 403 (-3.7A) | 0.76A | 4c1fA-6ao1A:18.64c1fB-6ao1A:18.4 | 4c1fA-6ao1A:19.734c1fB-6ao1A:19.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ao1 | BETA-LACTAMASEDOMAIN PROTEIN (Paraburkholderiaphymatum) |
PF00753(Lactamase_B) | 5 | HIS A 94HIS A 96ASP A 98HIS A 205ASN A 233 | CA A 404 (-3.4A) CA A 404 (-3.2A) CA A 403 (-3.0A) CA A 404 (-3.3A)None | 0.97A | 4c1fA-6ao1A:18.64c1fB-6ao1A:18.4 | 4c1fA-6ao1A:19.734c1fB-6ao1A:19.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6brm | PUTATIVEMETAL-DEPENDENTISOTHIOCYANATEHYDROLASE SAXA (Pectobacteriumcarotovorum) |
no annotation | 5 | HIS A 67HIS A 69ASP A 71HIS A 128HIS A 221 | ZN A 301 (-3.4A) ZN A 301 (-3.3A) ZN A 302 (-2.7A) ZN A 301 (-3.3A) ZN A 302 (-3.4A) | 0.92A | 4c1fA-6brmA:7.34c1fB-6brmA:7.4 | 4c1fA-6brmA:15.494c1fB-6brmA:15.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ch0 | - (-) |
no annotation | 5 | HIS C 118HIS C 120ASP C 122HIS C 198HIS C 266 | CO C 302 (-3.3A) CO C 302 ( 3.1A) CO C 301 ( 2.6A) CO C 302 ( 3.4A) CO C 301 ( 3.3A) | 0.76A | 4c1fA-6ch0C:15.74c1fB-6ch0C:15.7 | 4c1fA-6ch0C:undetectable4c1fB-6ch0C:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ch0 | - (-) |
no annotation | 5 | TRP C 26HIS C 118HIS C 120ASP C 122HIS C 198 | None CO C 302 (-3.3A) CO C 302 ( 3.1A) CO C 301 ( 2.6A) CO C 302 ( 3.4A) | 1.38A | 4c1fA-6ch0C:15.74c1fB-6ch0C:15.7 | 4c1fA-6ch0C:undetectable4c1fB-6ch0C:undetectable |